Animal Crossing characters visiting Omnipod Bay. [Image from Insulet/Nintendo]
Insulet (NSDQ:PODD) announced today that its Omnipod brand of products will feature on Nintendo’s Animal Crossing video game.Acton, Massachusetts-based Insulet aims to promote representation and inclusion for the diabetes community through an activation on Animal Crossing: New Horizons.
Get the full story at our sister site, Drug Delivery Business News.
Insulet (NSDQ:PODD) announced that Elizabeth (Bess) Weatherman was appointed to its board of directors.
Weatherman will stand for election by stockholders at the company’s 2022 annual meeting and has been named to the board’s Compensation Committee.
Get the full story at our sister site, Drug Delivery Business News.
FDA clearance for the next-generation version of the company’s wearable insulin delivery patch system covers individuals aged six years and older with type 1 diabetes. The platform provides easier glucose management, with no multiple daily injections, no tubes and zero fingersticks.
Get the full story at our sister site, Drug Delivery Business News.
Covering the medical device industry enables writers to report on a wide range of world-changing news – financial markets, the pandemic, and the global supply chain problems – while also centering on jaw-dropping technology that improve patient care.
You’ll hear all those issues covered in our editorial’s team summation of their Top Stories of 2021 recorded in our recent episode of the DeviceTalks Weekly Podcast.
The editors of our life sciences pages picked the stories that meant most to THEM in a very transformational year.
SeekingAlpha reported that Insulet CEO Shacey Petrovic, speaking at the Nasdaq Investor Conference, said the regulatory agency will likely not complete its review of the next-generation Omnipod 5 before the end of the year, meaning the launch projected for the fourth quarter of 2021 is now expected for the first quarter of 2022.
Get the full story at our sister site, Drug Delivery Business News.
Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek.
The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of the largest public corporations around. Companies were judged with an overall score out of 100 that combined environmental, social and corporate governance performance assessments.
Baxter, 3M, Abbott and BD (NYSE:BDX) were among the highest-ranking big-name medical device makers. Cancer diagnostic company Illumina was the highest-ranking company under the healthcare and life sciences umbrella, sitting in second behind HP.
In sixth sat Baxter, registering an overall score of 89.5 points, with its highest performance coming in environmental i…
Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial toll on the industry.
To compare performance before and during the pandemic, MDO used the financial data that we’ve historically gathered to rank our Big 100 companies in the last three years. The majority of these companies reported full-year results for 2020; others operate on a fiscal year and reported annual results in the first half of 2021.
Some companies are not in this year’s Big 100 but were included in the analysis because they were ranked in pre-pandemic years. The handful of companies that joined this yea…
[Photo by Martin Sanchez on Unsplash]
Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data.Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial toll on the industry.
To compare performance before and during the pandemic, MDO used the financial data that we’ve historically gathered to rank our Big 100 companies in the last three years. The majority of these companies reported full-year results for 2020; others operate on a fiscal year and reported annual results in the first half of 2021.
Some companies are not in this year’s Big 100 but were included in the analysis because they were ranked in pre…
World Diabetes Day (Nov. 14) may have passed, but it remains National Diabetes Month through the end of November.
A number of companies developing some of the most intriguing innovations in diabetes care have also stepped forward this month to organize awareness-raising efforts for the metabolic disease.
Here are some steps a handful of diabetes technology developers have made to try and bring more attention to diabetes management:
Get the full story at our sister site, Drug Delivery Business News.
World Diabetes Day — Nov. 14 — centers around raising awareness for those with diabetes.
This year, that aim remains the same, and medical technology companies continue to look for ways to continue improving the management of the metabolic disease.
Some of those treatments involve insulin, which was discovered as a treatment for diabetes in 1922 and remains a vital part of the standard of care. World Diabetes Day falls on Nov. 14 because it is the birthday of Frederick Banting, one of the scientists involved in discovering insulin as a treatment for diabetes.
However, while many medtech companies look for ways to make insulin accessible and efficient in treating diabetes, others are innovating treatment avenues outside of insulin. Regardless of the path chosen, all have created intriguing options for managing and treating diabetes. Here are seven innovations in diabetes treatment that are worth keeping an eye on:
Next>>World Diabetes Day — Nov. 14 — centers around raising awareness for those with diabetes.
This year, that aim remains the same, and medical technology companies continue to look for ways to continue improving the management of the metabolic disease.
Some of those treatments involve insulin, which was discovered as a treatment for diabetes in 1922 and remains a vital part of the standard of care. World Diabetes Day falls on Nov. 14 because it is the birthday of Frederick Banting, one of the scientists involved in discovering insulin as a treatment for diabetes.
However, while many medtech companies look for ways to make insulin accessible and efficient in treating diabetes, others are innovating treatment avenues outside of insulin. Regardless of the path chosen, all have created intriguing options for managing and treating diabetes. Here are seven innovations in diabetes treatment that are worth keeping an eye on:
Next>>World Diabetes Day — Nov. 14 — centers around raising awareness for those who live every day with diabetes.
This year, that aim remains the same, and medical technology companies all over the world continue to look for ways to help manage the metabolic disease.
Some of those treatments involve insulin, which was discovered as a treatment for diabetes in 1922 and remains the standard of care. World Diabetes Day falls on Nov. 14 because it is the birthday of Frederick Banting, one of the scientists who helped to discover insulin as a treatment for diabetes.
However, while many medtech companies look for ways to make insulin accessible and efficient in treating diabetes, others are innovating treatment avenues outside of insulin. Regardless of the path chosen, all have created intriguing options for helping to manage and treat diabetes. Here are seven innovations in diabetes treatment that are worth keeping an eye on:
Next>>